Binding of ochratoxin A to a urinary globulin: A new concept to account for gender difference in rat nephrocarcinogenic responses

International Journal of Molecular Sciences

Volumn 9, Issue 5, 2008, Pages 719-735

  Mantle, Peter G ^a   Nagy, Judit M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

2u globulin; Evidence based toxicology; Female rat; Gel electrophoresis; Immunoblotting; Mycotoxin; Nephrotoxicity; Ochratoxin A; Renal carcinoma; Risk assessment

Indexed keywords

ALPHA2U GLOBULIN; GLOBULIN; OCHRATOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIETARY INTAKE; GENDER; HISTOPATHOLOGY; IMMUNOBLOTTING; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; MALE; NEPHROTOXICITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PROTEIN INTERACTION; RAT; RISK ASSESSMENT;

RATTUS;

EID: 44649165139     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms9050719     Document Type: Article

References (47)

1. . Chu, F.S. A comparative study of the interaction of ochratoxins with bovine serum albumin. Biochem. Pharmacol. 1974, 23, 1105-1113.
2. Krogh, P. Causal associations of mycotoxic nephropathy. Acta Pathol. Microbiol. Scand. Sect A (Suppl.) 1978, 269, 28pp.
3. Schwerdt, G.; Freudinger, R.; Silbernagl, S.; Gekle, M.. Ochratoxin A-binding proteins in rat organs and plasma and in different cell lines of the kidney. Toxicology 1999, 135, 1-10.
4. Boorman, G.A. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47- 9) in F344/N Rats (Gavage Studies). 1989 National Toxicology Program. Technical Report 358.
5. IARC Monographs on the evaluation of carcinogenic risks of chemicals to humans. Vol. 59. Some naturally occurring substances: some food items and constituents, heterocyclic amines and mycotoxins. IARC, Lyon. (1993).
6. Buist, S.C.N.; Cherrington, N.J.; Choudhuri, S.; Hartley, D.P.; Klaassen, C.D. Gender-specific and developmental influences on the expression of rat organic ion transporters. J. Pharmacol. Exp. Ther. 2002, 301, 145-151.
7. Buist, S.C.N.; Cherrington, N.J.; Klaassen, C.J. Endocrine regulators of rat organic anion transporters. Drug Metab.Dispos. 2003, 31, 559-564.
8. Ljubojevic, M.; Herak-Kramberger, C.M.; Hagos, Y.; Bahn, A.; Endou, H.; Burckhardt, G.; Sabolic, I. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am. J. Renal Physiol. 2004, 287, F124-F138.
9. Zlender, V.; Ljubojevic M.; Balen, D.; Breljac, D.; Anzai, N.; Fuchs, R.; Sabolic, I. Expression of renal organic anion transporters OAT1 and OAT3 in ochratoxin-treated rats. Toxicol. Lett. 2006, 164 (Supplement 1), S81.
10. Marin-Kuan, M.; Nestler, S.; Verguet, C.; Bezencon, C.; Piguet, D.; Mansourian, R.; Holzwarth, J.; Grigorov, M.; Delatour, T.; Mantle, P.; Cavin, C.; Schilter, B. A toxicogenomics approach to identifying new plausible epigenetic mechanisms of ochratoxin A carcinogenicity in rat. Toxicol. Sci. 2006, 89, 120-134.
11. Heussner, A.H.; O'Brien, E.; Dietrich, D.R. Species- and sex-specific variations in binding of ochratoxin A by renal proteins in vitro. Exp.Toxic. Pathol. 2002, 54, 151-159.
12. Pfohl-Leszkowicz, A.; Manderville, R.A. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51, 61-99.
13. Bow, D.A.J.; Perry, J.L.; Simon, J.D.; Pritchard, J.B. The impact of plasma protein binding on the renal transport of organic anions. J. Pharmacol. Exp.Ther. 2006, 316, 349-355.
14. Pfohl-Leszkowicz, A.; Pinelli, E.; Bartsch, H.; Mohr, U.; Castegnaro, M. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol. Carcinog. 1998, 23, 76-85.
15. Castegnaro, M.; Mohr, U.; Pfohl-Leszkowicz, A.; Esteve, J.; Steinmann, J.; Tillmann, T.; Michelon, J.; Bartsch, H. Sex- and strain-specific induction of renal tumours by ochratoxin A in rats correlates with DNA addiction. Int. J. Cancer 1998, 77, 70-75.
16. Brown, A.; Odell, E.W.; Mantle, P.G. DNA ploidy distribution in renal tumours induced in male rats by dietary ochratoxin A. Exp. Toxic. Pathol. 2007, 59, 85-95.
17. Mantle, P.; Kulinskaya, E.; Nestler, S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Add. Contam., Supplement 1 2005, 58-64.
18. Swenberg, J.A.; Lehman-McKeeman, L.D. ?2-urinary globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats. In: Species differences in thyroid, kidney and urinary bladder carcinogenesis workshop. IARC Scientific Publication 1999, 147, 95-118.
19. Rasonyi, T.; Schlatter, J.; Dietrich, D.R. The role of alpha2u-globulin in ochratoxin A induced renal toxicity and tumours in F344 rats. Toxicol. Lett. 1999, 104, 83-92.
20. JECFA. 2001. Safety Evaluation of Certain Mycotoxins in Food. WHO, Geneva.
21. Gautier, J.-C.; Richoz, J.; Welti, D.H.; Markovic, J.; Gremaud, E.; Guengerich, F.P.; Turesky, R.J. Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes, Chem. Res.Toxicol. 2001, 14, 34-45.
22. Rached, E.; Pfeiffer, E.; Dekant, W.; Mally, A. Ochratoxin A: apoptosis and aberrant exit from mitosis due to perturbation. Toxicol. Sci. 2006, 92, 78-96.
23. Doi, A.M.; Hill, G.; Seely,J.; Hailey, J.R.; Kissling, G.; Bucher, J.R. α2u-globulin nephropathy and renal tumours in national toxicology program studies. Toxicol. Path. 2007, 35, 533-540.
24. Mally, A.; Pepe, G.; Ravoori, S.; Fiore, M.; Gupta, R.C.; Dekant, W.; Mosesso, P. Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 2005, 18, 1253-1261.
25. Chatterjee, B.; Motwani, N.M.; Roy, A.K. Synthesis and processing of the dimorphic forms of α2u-globulin. Bioch. Biophys. Acta 1982, 698, 22-28.
26. Roy, A.K.; Nath, T.S.; Motwani, N.M.; Chatterjee, B. Age-dependent regulation of the polymorphic forms of α2u-globulin. J. Biol. Chem. 1983, 258, 10123-10127.
27. Mantle, P.G. Interpretation of pharmacodynamics of ochratoxin A in blood plasma of rats, during and after acute or chronic ingestion. Food Chem. Toxicol. 2008, 46, 1808-1816.
28. Zepnik, H.; Volkel, W.; Dekant, W. Toxicokinetics of the mycotoxin ochratoxin A in F344 rats after oral administration. Toxicol. Appl. Pharmacol. 2003, 192, 36-44.
29. Miljkovic, A.; Pfohl-Leszkowicz, A.; Dobrota, M.; Mantle, P.G. Comparative responses to mode of oral administration and dose of ochratoxin A or nephrotoxic extract of Penicillium polonicum in rats. Exp. Toxic. Pathol. 2003, 54, 305-312.
30. Boorman, G.A.; McDonald, M.R.; Imoto, S.; Persing, R. Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol. Path. 1992, 20, 236-245.
31. Castegnaro, M.; Canadas, D.; Vrabcheva, T.; Petkova-Bocharova, T.; Chernozemsky, I.N.; Pfohl-Leszkowicz, A. Balkan endemic nephropathy: role of ochratoxins A through biomarkers. Mol. Nut. Food Res. 2006, 50, 519-529.
32. Chaudhuri, B.N.; Kleywegt, G.J.; Bjorkman, J.; Lehman-McKeeman, L.D.; Oliver, J.D.; Jones, T.A. The structures of α2u-globulin and its complex with a hyaline droplet inducer. Acta Cryst. 1999, D55, 753-762.
33. 1 mouse. J. Natl. Cancer Inst. 1985, 75, 733-739.
34. Bocskei, Zs.; Findlay, J.B.C.; North, A.C.T.; Phillips, S.E.V.; Somers, W.S.; Wright, C.E.; Lionetti, C.; Tirindelli, R.; Cavaggioni, A. Crystallisation of and preliminary x-ray data for the mouse major urinary protein and rat α2u-globulin. J. Molecular Biol. 1991, 218, 699-701.
35. Derman, E. Isolation of a cDNA clone for mouse urinary protein: age- and sex-related expression of mouse urinary protein genes is transcriptionally controlled. Proc. Natl. Acad. Sci.USA 1981, 78, 5425-5429.
36. th International IUPAC Symposium on Mycotoxins and Phycotoxins, Istanbul. May 2007.
37. Pfohl-Leszkowicz, A.; Manderville, R.A. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51, 61-99.
38. Waddell, W.J. Critique of dose response in carcinogenesis. Hum. Exp. Toxicol. 2006, 25, 413-436.
39. Lock, E.A.; Hard, G.C. Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. CRC Crit. Rev. Toxicol. 2004, 34, 211-299.
40. Guzelian, P.S.; Victoroff, M.S.; Halmes, N.C.; James, R.C.; Guzelian, C.P. Evidence-based toxicology: a comprehensive framework for causation. Hum. Exp. Toxicol. 2005, 24, 161-201.
41. Mantle, P.G.; Nagy, J. α2u-Globulin as a transporter of ochratoxin A, enhancing nephrotoxicity in male rats. Abstract 1045. X11th International IUPAC Symposium on Mycotoxins and Phycotoxins. May 2007, Istanbul.
42. Son, W.-C.; Kamino, K.; Lee, Y.-S.; Kang, K.-S. Strain-specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats. Int. J. Cancer 2003, 105, 305-311.
43. Son, W.-C.; Kamino, K.; Lee, Y.-S.; Kang, K.-S. Lack of effects of sodium 2-mercaptoethane sulfonate (mesna) on ochratoxin A induced renal tumourigenicuty following lifetime oral administration of ochratoxin A in DA and Lewis rats. Toxicol.Lett. 2003, 142, 19-27.
44. Mally, A.; Zepnik, H.; Wanek, P.; Eder, E.; Dingley, K.; Ihmels, H.; Volkel, W.; Dekant, W. Ochratoxin A: lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 2004, 17, 234-242.
45. Turesky, R. J. Perspective: Ochratoxin A is not a genotoxic carcinogen. Chem. Res. Toxicol. 2005, 17, 1082-1090.
46. EFSA, Opinion of the scientific panel on contaminants in the food chain on a request from the Commission related to ochrotoxin A in food. EFSA J. 2006, 365, 1-56. (www.efsa.eu.int)
47. Walker, R. Risk assessment of ochratoxin: current views of the European Scientific Committee on Food, the JECFA and the Codex Committee on Food Additives and Contaminants. Adv. Exp. Med. Biol. 2002,504, 249-255.